Ikarian Capital’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRX
Ikarian Capital's EPRX Position: Q3 2026 in Review
Ikarian Capital held its Eupraxia Pharmaceuticals (EPRX) position steady in Q3 2026 at 809,741 shares worth $7.37M. The position accounts for 0.74% of the portfolio, ranked #33.
Ikarian Capital first reported a position in EPRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $8.79M in Q1 2026. 70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.
- Ikarian Capital held 809,741 shares of Eupraxia Pharmaceuticals worth $7.37M as of Q3 2026.
- Ikarian Capital left its Eupraxia Pharmaceuticals share count unchanged in Q3 2026.
- Eupraxia Pharmaceuticals made up 0.74% of Ikarian Capital's portfolio in Q3 2026, its #33 holding.
- Ikarian Capital first reported a position in Eupraxia Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Ikarian Capital's Eupraxia Pharmaceuticals position peaked at $8.79M in Q1 2026.
- 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.
Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.